source
- STAT+: MIT says research has fallen 10%, and grad student enrollment is downAt MIT, research has shrunk 10% from a year ago, and the school expects a persistent drop in graduate admissions.STAT · 2mo ago↗ source
- Create Medicines raises $122M to bolster in vivo CAR-T therapiesThe fresh funds will support the biotech's pipeline of RNA-based CAR-T cell therapies for cancer and autoimmune conditions.BioPharma Dive · 2mo ago↗ source
- Biogen pushing tau drug forward despite Alzheimer’s study failureOne of the company’s more closely watched research assets, BIIB080 is now heading to late-stage testing based on “the strength of the biomarker and efficacy data” seen in a Phase 2 trial.BioPharma Dive · 2mo ago↗ source